Guest guest Posted February 17, 2001 Report Share Posted February 17, 2001 " Companies Weigh Offer of Royalties for AIDS Drugs Aimed at Africa " Wall Street Journal (02/16/01) P. B1; Pearl, Cipla has offered Bristol-Myers Squibb, Pfizer, GlaxoKline, and Boehringer Ingelheim a proposal in which it would gain the rights to sell generic versions of their patented AIDS drugs in Africa in exchange for a 5 percent royalty fee. If the pharmaceutical companies decline Cipla's offer, the generic maker could turn to compulsory licensing provisions to sell its product in Africa without paying royalties. Foreign aid and revenues could drop if countries grant compulsory licensing rights, reducing the likelihood that such action would be taken. Cipla has also offered to sell an array of AIDS drugs to the group Doctors Without Borders at a considerably lower price than what large pharmaceutical companies are willing to charge to underdeveloped countries. _________________________ Forwarded by: Rajesh M.Buddhadev MD E-mail: buddhadev@... Nisarg Skin,Cosmetology,Allergy,AIDS & Dermatosurgery centre 3-b Shashi Tower,Adajan Patia,Rander Road,SURAT-395009 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.